Tu1484 Endoscopic Radio-Frequency Ablation of Biliary Strictures Unleashed: A Case Series in a Variety of Clinical Scenarios

2017 ◽  
Vol 85 (5) ◽  
pp. AB646
Author(s):  
Melissa Jimenez Morales ◽  
Jose-Guillermo De La Mora-Levy ◽  
Cesar R. Ortega Espinosa ◽  
Juan O. Alonso-Larraga ◽  
Mauro E. Ramírez-Solís ◽  
...  
Keyword(s):  
Radio Frequency ◽  
Case Series ◽  
Radio Frequency Ablation ◽  
Biliary Strictures ◽  
Clinical Scenarios

Partial radio frequency ablation of spleen in patients with thalassemia: a case series

2011 ◽  
Author(s):  
Mozhgan Hashemieh ◽  
Shahram Akhlaghpoor ◽  
Azita Azarkeivan ◽  
Alireza Azizahari ◽  
Afshan Shirkavand ◽  
...  
Keyword(s):  
Radio Frequency ◽  
Case Series ◽  
Radio Frequency Ablation

Cooled Radio Frequency Ablation for the Treatment of Osteoarthritis-Related Knee Pain: Evidence, Indications, and Outcomes

2018 ◽  
Vol 32 (01) ◽  
pp. 065-071 ◽  
Author(s):  
Lasun Oladeji ◽  
James Cook
Keyword(s):  
Pain Relief ◽  
Radio Frequency ◽  
Knee Pain ◽  
Surgical Intervention ◽  
Case Reports ◽  
Treatment Algorithm ◽  
Case Series ◽  
Radio Frequency Ablation ◽  
Chronic Knee Pain ◽  
Early Results

AbstractKnee osteoarthritis (OA) is a common condition associated with pain and physical impairment in a large segment of the population. The traditional treatment algorithm progresses from conservative modalities to nonsurgical options to surgical intervention. Surgical intervention often provides reliable pain relief but not all patients are surgical candidates and there are some patients who prefer not to have surgery. Cooled radio frequency ablation (C-RFA) is a treatment with the potential to provide pain relief for patients who no longer benefit from noninvasive modalities and who desire an alternative to surgery. The objective of this review article is to provide the rationale, available evidence, indications, and outcomes associated with C-RFA for the treatment of chronic knee OA. A total of eight reports that use C-RFA in the treatment of chronic knee pain were identified and analyzed. There were two prospective trials, one retrospective cohort study, and five case reports or case series. C-RFA is an emerging procedure with encouraging early results; however, additional long-term prospective clinical trials are necessary to further characterize how C-RFA can best be used to treat chronic knee pain.

scholarly journals Radiofrequency Ablation of the SupraOrbital Nerve in the Treatment Algorithm of Hemicrania Continua

2012 ◽  
Vol 5;15 (5;9) ◽  
pp. E719-E724
Author(s):  
Leena Mathew
Keyword(s):  
Radiofrequency Ablation ◽  
Radio Frequency ◽  
Medical Management ◽  
Treatment Algorithm ◽  
Case Series ◽  
Primary Headache ◽  
Hemicrania Continua ◽  
Radio Frequency Ablation ◽  
Invasive Technique ◽  
Supraorbital Nerve

Hemicrania continua (HC) is an uncommon primary headache disorder in which the diagnosis centers on unilaterality and its absolute responsiveness to indomethacin. We describe 3 patients with a long standing history of headache diagnosed as hemicrania continua. There was profound response to indomethacin which was limited by side effects. In one patient the therapy with indomethacin was limited secondary to comorbidities. Initial diagnostic blockade provided significant relief of symptoms based on which radio-frequency ablation of the supraorbital nerve was performed with substantial improvement in symptoms. Traditionally, hemicrania continua has been managed exclusively with oral analgesics and is defined by its singular response to indomethacin. Radio-frequency ablation (RFA) has been reported in the literature for multiple indications. This case series is unique in that it describes 3 patients diagnosed with hemicrania continua with pain referred in the supraorbital nerve distribution, who underwent radiofrequency ablation of the supraorbital nerve with resultant resolution of headaches. Traditionally, hemicrania continua has been managed exclusively with oral analgesics and is defined by its singular response to indomethacin. This report is unique in that it describes three patients diagnosed with hemicrania continua with pain referred in the supraorbital nerve distribution who underwent radiofrequency ablation of the supraorbital nerve with resultant resolution of headaches. After the RFA medical management was minimal to none in both patients. Though the utility and cost efficacy of RFA of peripheral nerves needs to be confirmed in well-designed trials we present these cases as an example of how this minimally invasive technique can safely provide analgesia in a difficult to treat cephalgia. Moreover if precise anatomical localization of the headache is possible then diagnostic blockade of the appropriate peripheral nerve may be performed followed by radiofrequency ablation to provide potentially more sustained analgesia in patients where medical management is ineffective or poorly tolerated. Key words: Headache, hemicrania continua, radio-frequency ablation

46: Intermediate Follow-Up Comparison between Partial Nephrectomy and Radio Frequency Ablation in T1A Renal Tumors

2006 ◽  
Vol 175 (4S) ◽  
pp. 16-16 ◽  
Author(s):  
Joshua M. Stern ◽  
Robert S. Svatek ◽  
Sangtae Park ◽  
J. Kyle Anderson ◽  
Yair Lotan ◽  
...  
Keyword(s):  
Radio Frequency ◽  
Partial Nephrectomy ◽  
Radio Frequency Ablation ◽  
Renal Tumors

scholarly journals Impact of DaTscan Imaging on Clinical Decision Making in Clinically Uncertain Parkinson’s Disease

2021 ◽  
pp. 1-5
Author(s):  
Jonathan R. Isaacson ◽  
Salima Brillman ◽  
Nisha Chhabria ◽  
Stuart H. Isaacson
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Clinical Diagnosis ◽  
Clinical Decision Making ◽  
Photon Emission ◽  
Case Series ◽  
Emission Computed Tomography ◽  
Medication Therapy ◽  
Clinical Scenarios ◽  
The Impact

Background: The diagnosis of Parkinson’s disease (PD) is primarily clinical, but in cases of diagnostic uncertainty, evaluation of nigrostriatal dopaminergic degeneration (NSDD) by imaging of the dopamine transporter using DaTscan with single-photon emission computed tomography (SPECT) brain imaging may be helpful. Objective/Methods: In the current paper, we describe clinical scenarios for which DaTscan imaging was used in a prospective case series of 201 consecutive patients in whom a movement disorder specialist ordered DaTscan imaging to clarify NSDD. We describe the impact of DaTscan results on changing or confirming pre-DaTscan clinical diagnosis and on post-DaTscan treatment changes. Results/Conclusion: DaTscan imaging can be useful in several clinical scenarios to determine if NSDD is present. These include in patients with early subtle symptoms, suboptimal response to levodopa, prominent action tremor, drug-induced parkinsonism, and in patients with lower extremity or other less common parkinsonism clinical presentations. We also found DaTscan imaging to be useful to determine underlying NSDD in patients with PD diagnosis for 3-5 years but without apparent clinical progression or development of motor fluctuations. Overall, in 201 consecutive patients with clinically questionable NSDD, DaTscan was abnormal in 58.7% of patients, normal in 37.8%, and inconclusive in 3.5%. DaTscan imaging changed clinical diagnosis in 39.8% of patients and led to medication therapy changes in 70.1% of patients.

Sign in / Sign up

Export Citation Format

Share Document